The SA Health Products Regulatory Authority (SAHPRA) has appealed to the National Treasury for more funding, warning of operational risks due to over-reliance on fee income.
SAHPRA calls for Increased National Treasury funding
Original Article by Tamar Kahn | Business Day | 17 October 2024
The SA Health Products Regulatory Authority (SAHPRA) has appealed to the National Treasury for more funding, warning of operational risks due to over-reliance on fee income.
More Posts
Compounded semaglutide appeal dismissed
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
Read more...
WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Read more...
Unpaid specialist training strains SA doctors
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Read more...